Ranitidine

Product NDC
33261-202
11-digit product format
332610202
Labeler code
33261
Product ID
33261-202_99a8f78f-d074-4c2a-8dff-b0637b2a2324
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ranitidine
Dosage form
TABLET
Route
ORAL
Labeler
Aidarex Pharmaceuticals LLC
Application
ANDA077824
Marketing category
ANDA
Marketing start
2009-12-16
Marketing end
0000-00-00
Substance
RANITIDINE HYDROCHLORIDE
Active strength
300 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 11 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct33261-202IInactivated by FDA2026-08-17
excluded productproduct33261-202DDiscontinued by firm2026-08-17
excluded packagepackage33261-20233261-202-00IInactivated by FDA2026-08-17
excluded packagepackage33261-20233261-202-02IInactivated by FDA2026-08-17
excluded packagepackage33261-20233261-202-30IInactivated by FDA2026-08-17
excluded packagepackage33261-20233261-202-60IInactivated by FDA2026-08-17
excluded packagepackage33261-20233261-202-90IInactivated by FDA2026-08-17
excluded packagepackage33261-20233261-202-02DDiscontinued by firm2026-08-17
excluded packagepackage33261-20233261-202-30DDiscontinued by firm2026-08-17
excluded packagepackage33261-20233261-202-60DDiscontinued by firm2026-08-17
excluded packagepackage33261-20233261-202-90DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 4 · 186 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductIInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-02IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-30IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-60DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-60IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-90DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-90IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-30DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage33261-202-00IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductIInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-02IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-30IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-60DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-60IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-90DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-90IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-30DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage33261-202-00IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-02IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-02DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-30IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-60DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-60IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-90DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-90IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-30DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage33261-202-00IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-02IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-02DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-30IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-60DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-60IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-90DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-90IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-30DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage33261-202-00IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-02IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-02DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-30IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-60DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-60IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-90DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-90IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-30DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage33261-202-00IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage33261-202-02IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage33261-202-02DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage33261-202-30IInactivated by FDAcdf11ea48f46…ba0047e9e063…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077824-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13
A077824-002RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13caaa826d4ba7…
2026-08-18 06:07:402026-07A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-1303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-132680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-135bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13d06236e962d9…
2024-10-29 15:01 UTC2024-10A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-1379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-131e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-138072bd15b7f6…
2024-05-31 18:47 UTC2024-05A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-135c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-135d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-134b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORALAB2006-10-1374a2ff9319b5…
2019-12-13 00:20 UTC2019-12A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORALABRS2006-10-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077824-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2006-10-13bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A077824-002RANITIDINE HYDROCHLORIDEEQ 300MG BASETABLET / ORAL2006-10-13bb7c543d1eb4…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A077824-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A077824-002AB174a2ff9319b5…
2019-12-14 00:12 UTC2019-12A077824-001AB13f01610625f2…
2019-12-14 00:12 UTC2019-12A077824-002AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A077824-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A077824-002AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A077824-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A077824-002AB1ea99ee380514…

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7f54af34-be54-4c3c-894f-78df6452d747Product name320190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850Product name520190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7bProduct name120180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228Product name120160720

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33261-202-00Ranitidine100 in 1 BOTTLETABLET1007
33261-202-02Ranitidine120 in 1 BOTTLETABLET1207
33261-202-30Ranitidine30 in 1 BOTTLETABLET307
33261-202-60Ranitidine60 in 1 BOTTLETABLET607
33261-202-90Ranitidine90 in 1 BOTTLETABLET907

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
33261-202-00EA - Each33261-2029fc6b1d7-c932-4797-b893-c0ce0881ae5712017-12-14
33261-202-02EA - Each33261-2026ba72666-68dd-4b4a-9f7e-dff0c24e614212015-10-02
33261-202-30EA - Each33261-202c120a0c4-6ede-4ab2-9bc0-616642274a1b12015-10-02
33261-202-60EA - Each33261-202a9419eb8-2709-4ef8-8cb6-36d2644c3dd412015-10-02
33261-202-90EA - Each33261-2023e7578a4-c346-4252-a704-01ce313bad0612015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHMRANITIDINE TABLET [AIDAREX PHARMACEUTICALS LLC]2
RANITIDINEACTIVE MOIETY884KT10YB7RANITIDINE TABLET [AIDAREX PHARMACEUTICALS LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33261-202RANITIDINE TABLET [AIDAREX PHARMACEUTICALS LLC]7Legacy NDC, 5 package rows20171117_9add19e6-f71c-4950-ae63-90e152a9cfe0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RanitidineRANITIDINEAmneal Pharmaceuticals of New York LLCb38a3332-5c54-453f-aeb7-070f830955c22026-05-01Adverse reactionsExact identifier
application applno (ANDA): 077824
application number: ANDA077824

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198191ranitidine 150 MG Oral TabletPSN9add19e6-f71c-4950-ae63-90e152a9cfe07
198193ranitidine 300 MG Oral TabletPSN9add19e6-f71c-4950-ae63-90e152a9cfe07
198191ranitidine 150 MG Oral TabletSCD9add19e6-f71c-4950-ae63-90e152a9cfe07
198193ranitidine 300 MG Oral TabletSCD9add19e6-f71c-4950-ae63-90e152a9cfe07
198191ranitidine 150 MG (as ranitidine HCl 168 MG) Oral TabletSY9add19e6-f71c-4950-ae63-90e152a9cfe07
198193ranitidine 300 MG (as ranitidine HCl 336 MG) Oral TabletSY9add19e6-f71c-4950-ae63-90e152a9cfe07

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
33261-202-0033261020200100 in 1 BOTTLEHistorical
33261-202-0233261020202120 in 1 BOTTLEHistorical
33261-202-303326102023030 in 1 BOTTLEHistorical
33261-202-603326102026060 in 1 BOTTLEHistorical
33261-202-903326102029090 in 1 BOTTLEHistorical